Disease Activity Criteria Impact Dosing Interval Assignment in nAMD Trials

Ophthalmol Retina. 2024 Dec 27:S2468-6530(24)00617-1. doi: 10.1016/j.oret.2024.12.021. Online ahead of print.
No abstract available